Andrew Whittle

Business Development, Cardio-Renal-Metabolic

Role
Global Head of Bd & L, Cardio-renal-metabolic at Boehringer Ingelheim
Location
Cambridge, MA, US
LinkedIn followers
500 followers

About Andrew Whittle

I build creative partnerships with scientists and biotech companies, and seek transformational solutions for treating disease. An experienced biologist, specializing in drug development for cardiometabolic diseases, I thrive when pursuing innovative ways to improve human health.

Experience

  1. Global Head of Bd & L, Cardio-renal-metabolic

    Boehringer Ingelheim

    Feb 2025 — Present · Boston, MA, US

Education

  • University of Cambridge

    Ph.D, Biology (metabolism)

    2006 — 2011

  • The University of Manchester

    B.Sc, Cell Biology

    2002 — 2006

Skills

  • Tissue Culture
  • Polymerase Chain Reaction (Pcr)
  • Real-Time Polymerase Chain Reaction (Qpcr)
  • Research
  • Biochemistry
  • Biotechnology
  • In Vivo
  • Immunohistochemistry
  • Qpcr
  • Cell Culture
  • Molecular Cloning
  • Animal Models
  • Neurobiology
  • Science
  • In Vitro
  • Drug Discovery
  • Life Sciences
  • Cell Signaling
  • Confocal Microscopy
  • Microscopy
  • Genetics
  • Biology
  • Molecular Biology
  • Fluorescence Microscopy
  • Laboratory
  • Lifesciences
  • Protein Expression
  • Cell Biology
  • Scientific Writing
  • Pcr
  • Data Analysis
  • Metabolism
  • Project Planning
  • Project Management
  • Neuroscience
  • Western Blotting

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Andrew Whittle — Global Head of Bd & L, Cardio-renal-metabolic at Boehringer Ingelheim in Cambridge, MA, US | Unifers